{"name":"Iroquois Capital","permalink":"iroquois-capital","crunchbase_url":"http://www.crunchbase.com/financial-organization/iroquois-capital","homepage_url":"","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"212-974-3070","description":"capital fund","email_address":"","number_of_employees":null,"founded_year":2003,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Tue Sep 29 08:58:21 UTC 2009","updated_at":"Tue Sep 29 08:59:59 UTC 2009","overview":"<p>Iroquois Capital, LP is a private equity and venture capital firm specializing in seed or start-up, early, mid, and late venture; turnarounds; growth capital; and PIPE investments. It seeks to invest in all industries. The firm also manages hedge funds for its clients. Iroquois Capital, LP was founded in 2003 and is based in New York, New York.</p>","image":null,"offices":[{"description":"HQ","address1":"641 Lexington Avenue","address2":"26th Floor","zip_code":"10022","city":"New York","state_code":"NY","country_code":"USA","latitude":null,"longitude":null}],"relationships":[],"investments":[{"funding_round":{"round_code":"unattributed","source_url":"http://www.antigenics.com/news/2009/0804.phtml","source_description":"Antigenics to Raise $10 Million in Private Placement","raised_amount":9350000,"raised_currency_code":"USD","funded_year":2009,"funded_month":8,"funded_day":4,"company":{"name":"Antigenics","permalink":"antigenics","image":{"available_sizes":[[[150,85],"assets/images/resized/0006/1112/61112v1-max-150x150.png"],[[171,97],"assets/images/resized/0006/1112/61112v1-max-250x250.png"],[[171,97],"assets/images/resized/0006/1112/61112v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.cel-sci.com/press_42.html","source_description":"CEL-SCI SIGNS DEFINITIVE AGREEMENT TO RAISE $4.4 MILLION IN REGISTERED DIRECT OFFERING","raised_amount":4400000,"raised_currency_code":"USD","funded_year":2009,"funded_month":8,"funded_day":20,"company":{"name":"CEL-SCI","permalink":"cel-sci","image":{"available_sizes":[[[150,56],"assets/images/resized/0006/1134/61134v1-max-150x150.jpg"],[[182,69],"assets/images/resized/0006/1134/61134v1-max-250x250.jpg"],[[182,69],"assets/images/resized/0006/1134/61134v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Cap Funding Report","raised_amount":3980000,"raised_currency_code":"USD","funded_year":2006,"funded_month":3,"funded_day":10,"company":{"name":"Migo Software","permalink":"migo-software","image":{"available_sizes":[[[150,106],"assets/images/resized/0008/4267/84267v1-max-150x150.jpg"],[[164,116],"assets/images/resized/0008/4267/84267v1-max-250x250.jpg"],[[164,116],"assets/images/resized/0008/4267/84267v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Cap Funding Report","raised_amount":18600000,"raised_currency_code":"USD","funded_year":2006,"funded_month":11,"funded_day":7,"company":{"name":"EUSA Pharma","permalink":"eusa-pharma","image":{"available_sizes":[[[150,33],"assets/images/resized/0005/9049/59049v2-max-150x150.png"],[[250,55],"assets/images/resized/0005/9049/59049v2-max-250x250.png"],[[263,58],"assets/images/resized/0005/9049/59049v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Cap Funding Report","raised_amount":12530000,"raised_currency_code":"USD","funded_year":2005,"funded_month":12,"funded_day":13,"company":{"name":"EUSA Pharma","permalink":"eusa-pharma","image":{"available_sizes":[[[150,33],"assets/images/resized/0005/9049/59049v2-max-150x150.png"],[[250,55],"assets/images/resized/0005/9049/59049v2-max-250x250.png"],[[263,58],"assets/images/resized/0005/9049/59049v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Cap Funding Report","raised_amount":7630000,"raised_currency_code":"USD","funded_year":2005,"funded_month":7,"funded_day":27,"company":{"name":"Pharmacopeia","permalink":"pharmacopeia","image":null}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Cap funding Report","raised_amount":866000,"raised_currency_code":"USD","funded_year":2010,"funded_month":5,"funded_day":17,"company":{"name":"TapImmune","permalink":"tapimmune","image":{"available_sizes":[[[150,108],"assets/images/resized/0009/2595/92595v1-max-150x150.jpg"],[[202,146],"assets/images/resized/0009/2595/92595v1-max-250x250.jpg"],[[202,146],"assets/images/resized/0009/2595/92595v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.dorbiopharma.com/news.aspx?titleId=351","source_description":"Soligenix Announces Private Equity Financing of $5.16 Million with its Partner Sigma-Tau and other Institutional Investors","raised_amount":5160000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":16,"company":{"name":"Soligenix","permalink":"soligenix","image":{"available_sizes":[[[150,42],"assets/images/resized/0009/2621/92621v1-max-150x150.jpg"],[[250,70],"assets/images/resized/0009/2621/92621v1-max-250x250.jpg"],[[357,100],"assets/images/resized/0009/2621/92621v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.senesco.com/newsitem.php?id=197","source_description":"Senesco Technologies, Inc. Announces Private Placement Financing for Gross Proceeds of $11.5 Million. Funds to be Utilized to Advance Lead Multiple Myeloma Drug Candidate into Phase 1b/2a Clinical Trial ","raised_amount":11500000,"raised_currency_code":"USD","funded_year":2010,"funded_month":3,"funded_day":29,"company":{"name":"Senesco Technologies","permalink":"senesco-technologies","image":{"available_sizes":[[[150,79],"assets/images/resized/0009/4397/94397v1-max-150x150.png"],[[174,92],"assets/images/resized/0009/4397/94397v1-max-250x250.png"],[[174,92],"assets/images/resized/0009/4397/94397v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Cap Funding Report","raised_amount":4610000,"raised_currency_code":"USD","funded_year":2010,"funded_month":2,"funded_day":24,"company":{"name":"SinoHub","permalink":"sinohub","image":{"available_sizes":[[[150,37],"assets/images/resized/0009/6701/96701v1-max-150x150.jpg"],[[194,49],"assets/images/resized/0009/6701/96701v1-max-250x250.jpg"],[[194,49],"assets/images/resized/0009/6701/96701v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Cap Funding Report","raised_amount":1540000,"raised_currency_code":"USD","funded_year":2010,"funded_month":2,"funded_day":4,"company":{"name":"Digital Angel","permalink":"digital-angel","image":{"available_sizes":[[[150,43],"assets/images/resized/0006/3607/63607v1-max-150x150.jpg"],[[250,72],"assets/images/resized/0006/3607/63607v1-max-250x250.jpg"],[[309,90],"assets/images/resized/0006/3607/63607v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Cap funding Report","raised_amount":1000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":3,"funded_day":16,"company":{"name":"Biomoda","permalink":"biomoda","image":{"available_sizes":[[[150,37],"assets/images/resized/0009/4655/94655v1-max-150x150.jpg"],[[250,62],"assets/images/resized/0009/4655/94655v1-max-250x250.jpg"],[[342,86],"assets/images/resized/0009/4655/94655v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Cap Funding Report","raised_amount":2300000,"raised_currency_code":"USD","funded_year":2005,"funded_month":3,"funded_day":31,"company":{"name":"ACE*COMM","permalink":"ace-comm","image":null}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Cap Funding Report","raised_amount":6500000,"raised_currency_code":"USD","funded_year":2005,"funded_month":8,"funded_day":16,"company":{"name":"BravoSolution","permalink":"bravosolution","image":{"available_sizes":[[[150,44],"assets/images/resized/0006/4567/64567v1-max-150x150.png"],[[217,65],"assets/images/resized/0006/4567/64567v1-max-250x250.png"],[[217,65],"assets/images/resized/0006/4567/64567v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://ir.raptorpharma.com/phoenix.zhtml?c=198466&p=irol-newsArticle&ID=1458272&highlight=","source_description":"Raptor Pharmaceutical Announces Pricing of $15 Million PIPE Financing","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":8,"funded_day":9,"company":{"name":"Raptor Pharmaceuticals","permalink":"raptor-pharmaceuticals","image":{"available_sizes":[[[150,45],"assets/images/resized/0010/8069/108069v1-max-150x150.png"],[[233,70],"assets/images/resized/0010/8069/108069v1-max-250x250.png"],[[233,70],"assets/images/resized/0010/8069/108069v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://ir.oncothyreon.com/releasedetail.cfm?ReleaseID=510806","source_description":" Oncothyreon Announces Pricing of $14.9 Million Private Placement","raised_amount":14900000,"raised_currency_code":"USD","funded_year":2010,"funded_month":9,"funded_day":24,"company":{"name":"Oncothyreon","permalink":"oncothyreon","image":{"available_sizes":[[[150,36],"assets/images/resized/0010/0796/100796v1-max-150x150.png"],[[250,60],"assets/images/resized/0010/0796/100796v1-max-250x250.png"],[[324,79],"assets/images/resized/0010/0796/100796v1-max-450x450.png"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}